Annual research & development funding for infectious diseases, 2020

Global annual funding reported for research and development to address neglected tropical diseases (in blue). These are compared to HIV/AIDS, tuberculosis,malaria, and COVID-19 (in orange). This data is expressed in US dollars, adjusted for inflation.

$6.12 billion$1.53 billion$758.05 million$696.22 million$83.62 million$50.5 million$46.99 million$40.48 million$25.61 million$19.1 million$16.8 million$13.13 million$8.95 million$7.36 million$4.76 million$3.39 million$2.66 million$1.99 million$1.96 million$1.29 million$771,511COVID-19HIV/AIDSTuberculosisMalariaDengueLeishmaniasisChagas diseaseChikungunyaSchistosomiasisRiver blindnessSnakebite envenomingLymphatic filariasisLeprosyTapewormHookwormWhipwormBuruli ulcerRoundwormTrachomaScabiesMycetoma
Annual research & development funding for infectious diseases

Interactive visualization requires JavaScript